Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02594670
Other study ID # 2014CB543102-1
Secondary ID
Status Not yet recruiting
Phase N/A
First received September 30, 2014
Last updated November 2, 2015
Start date October 2015
Est. completion date August 2017

Study information

Verified date March 2015
Source The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Contact Yan Wang
Email 48770045@qq.com
Is FDA regulated No
Health authority China: State Administration of Traditional Chinese Medicine of the People's Republic of China
Study type Interventional

Clinical Trial Summary

Selecting different acupoints as an combination of acupoints is a key factor to clinical efficacy of acupuncture. Different combinations of acupoints will generate different clinical efficacy. So,the purpose of this study is to determine the different clinical efficacy among three types of combinations of acupoints in the treatment of primary insomnia.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 333
Est. completion date August 2017
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- Diagnosed as insomnia based on the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition,2013, American psychiatric association

- PSQI score >7

- AIS score =6

- SDS =60

- SAS =60

- Age between 18 and 65 years old

- Not involved in other clinical trial in the lasted 6 months before screening

- Have the ability to write the informed consent.

Exclusion Criteria:

- Breathing-related sleep disorders

- Circadian rhythm sleep-wake disorders

- Medication-induced sleep disorder

- Substance induced sleep disorders,such as alcohol, coffee, strong tea

- Secondary insomnia caused by systemic diseases or caused by external environment disturbance

- Pregnant or lactating women

- Combined with serious cardiovascular, lung, liver, kidney, hematopoietic system, and mental diseases

- Advanced malignant tumor or other serious debilitating diseases

- Location of acupoints combined with infection and bleeding

- Declined to acupuncture

- Couldn't provide the written informed consent.

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Sleep Initiation and Maintenance Disorders

Intervention

Other:
DU20 and HT7 combination
acupoints combination includes Baihui (DU20) and Shenmen(HT7),which was considered as the optimal clinical efficay among various combinations of acupoints.
DU20 and SP6 combination
acupoints combination of Baihui (DU20) and Sanyinjiao (SP6), which should have some clinical efficay among various combinations of acupoints.
DU20 and SA combination
Combination of Baihui (DU20) and a Sham acupoint (SA), which should have least clinical efficacy among these three types of acupoints combinations.

Locations

Country Name City State
China First Hospital of Hunan University of Chinese Medicine Changsha Hunan
China Second Hospital of Hunan University of Chinese Medicine Changsha Hunan
China Hengyang hospital of Hunan University of Chinese Medicine Hengyang Hunan

Sponsors (3)

Lead Sponsor Collaborator
The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine Ministry of Science and Technology of the People´s Republic of China, University of British Columbia

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Other safety evaluation will summarize the incidence of adverse events,including itching and redness of local acupoints. 4 weeks Yes
Other adherence of acupuncture adherence to the treatment (adherence rate)will be calculated using formula: Adherence Rate = Number of Treatment Conducted/ Number of Treatment Planned 4 weeks Yes
Primary Pittsburgh sleep quality index (PSQI) 4 weeks No
Secondary Athens Insomnia Scale (AIS) 4 weeks and 8 weeks No
Secondary Short Form 36-item Health Survey(SF-36) 4 weeks and 8 weeks No
Secondary Self-anxiety scale (SAS) 4 weeks and 8 weeks No
Secondary Self-depression scale (SDS) 4 weeks and 8 weeks No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT03276585 - Night in Japan Home Sleep Monitoring Study
Recruiting NCT05000528 - Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia N/A
Completed NCT04661306 - The Better Sleep for Supporters With Insomnia Study N/A
Completed NCT03673397 - The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression N/A
Completed NCT01784614 - A Study of LY2624803 in Japanese Participants With Transient Insomnia Phase 1
Completed NCT00365261 - Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer Phase 4
Completed NCT00380003 - Efficacy Study of EVT 201 to Treat Insomnia Phase 2
Completed NCT00183378 - Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease N/A
Completed NCT00097604 - Effects of Valerian on Sleep in Healthy Older Adults Phase 2
Completed NCT00946530 - Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease N/A
Completed NCT00630175 - Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia Phase 3
Completed NCT00079664 - Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults Phase 1
Completed NCT00044629 - Combined Behavioral/Pharmacological Therapy for Insomnia Phase 2
Completed NCT01154023 - Behavioral Intervention for Insomnia in Older Adults N/A
Recruiting NCT04417153 - Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
Completed NCT04560595 - Remote Guided Caffeine Reduction N/A
Recruiting NCT04986007 - Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults N/A
Completed NCT03852966 - Better Sleep in Psychiatric Care - ADHD Pilot Study N/A
Terminated NCT00750919 - Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007) Phase 3
Recruiting NCT04550507 - Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents N/A